From: Jérôme Hénin (jerome.henin_at_ibpc.fr)
Date: Tue Dec 01 2020 - 13:30:54 CST
----- On 1 Déc 20, at 17:27, Matthew Guberman-Pfeffer matthew.guberman-pfeffer_at_yale.edu wrote:
> Dear NAMD community,
> I want to study how one or more residue mutations impact the stability of a
> protein-protein complex. I've worked through the tutorial on alchemical
> transformations, but I have some additional questions, and would appreciate
> advice on how to set options that have since been implemented in NAMD.
> 1) Should I minimize/equilibrate the bound and unbound protein that will
> undergo mutations before or after creating the hybrid topology? Does it
For efficiency, you can equilibrate the initial state alone, then create the hybrid, then do a very quick minimization if needed to ensure the new tolopogy has a correct geometry.
> 2) How do you choose the value of alchLambdaIDWS?
You don't have to do it explicitly if you use the FEP scripts in fep.tcl, it is set automatically to the previous lambda value if applicable.
> 3) When is it appropriate to use alchWCA/alchRepLambdaEnd or
> alchBondLambdaEnd/alchBondDecouple. If so, again, how do you choose the
> appropriate settings?
These are all niche options. If you're unsure what they are, then you don't need them.
This archive was generated by hypermail 2.1.6 : Fri Dec 31 2021 - 23:17:10 CST